Related references
Note: Only part of the references are listed.Associations Between Physical Activity, Blood-Based Biomarkers of Neurodegeneration, and Cognition in Healthy Older Adults: The MAPT Study
Jeremy Raffin et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2021)
The Complex Relationship Between Serum Uric Acid, Endothelial Function and Small Vessel Remodeling in Humans
Stefano Masi et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
D. Allan Butterfield et al.
NATURE REVIEWS NEUROSCIENCE (2019)
Urate and risk of Alzheimer's disease and vascular dementia: A population-based study
Lieke E. J. M. Scheepers et al.
ALZHEIMERS & DEMENTIA (2019)
Effect of allopurinol in addition to hypothermia treatment in neonates for hypoxic-ischemic brain injury on neurocognitive outcome (ALBINO): study protocol of a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III)
Christian A. Maiwald et al.
BMC PEDIATRICS (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Uric acid and cognitive decline: a double-edge sword?
Augustin Latourte et al.
CURRENT OPINION IN RHEUMATOLOGY (2018)
Hyperuricemia and dementia - a case-control study
Bettina Engel et al.
BMC NEUROLOGY (2018)
Inflammaging: a new immune-metabolic viewpoint for age-related diseases
Claudio Franceschi et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Gout and dementia in the elderly: a cohort study of Medicare claims
Jasvinder A. Singh et al.
BMC GERIATRICS (2018)
Uric acid and incident dementia over 12 years of follow-up: a population-based cohort study
Augustin Latourte et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Comparative effectiveness of allopurinol versus febuxostat for preventing incident dementia in older adults: a propensity-matched analysis
Jasvinder A. Singh et al.
ARTHRITIS RESEARCH & THERAPY (2018)
2016 updated EULAR evidence-based recommendations for the management of gout
P. Richette et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Uric acid may be protective against cognitive impairment in older adults, but only in those without cardiovascular risk factors
Busra Tuven et al.
EXPERIMENTAL GERONTOLOGY (2017)
Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial
Sandrine Andrieu et al.
LANCET NEUROLOGY (2017)
Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors
David Lagorce et al.
SCIENTIFIC REPORTS (2017)
Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study
Na Lu et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis
Aamir A. Khan et al.
AGE (2016)
Allopurinol protects against ischemic insults in a mouse model of cortical microinfarction
Qun Zhang et al.
BRAIN RESEARCH (2015)
Effects of Febuxostat on Oxidative Stress
Toshiki Fukui et al.
CLINICAL THERAPEUTICS (2015)
A Mendelian Randomization Study of Circulating Uric Acid and Type 2 Diabetes
Ivonne Sluijs et al.
DIABETES (2015)
Management of gout in general practice-a systematic review
Andrew Jeyaruban et al.
CLINICAL RHEUMATOLOGY (2015)
The source of cognitive complaints predicts diagnostic conversion differentially among nondemented older adults
Katherine A. Gifford et al.
ALZHEIMERS & DEMENTIA (2014)
Cost-Effectiveness of Allopurinol and Febuxostat for the Management of Gout
Eric Jutkowitz et al.
ANNALS OF INTERNAL MEDICINE (2014)
Improving cardiovascular and renal outcomes in gout: what should we target?
Pascal Richette et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
The Preclinical Alzheimer Cognitive Composite Measuring Amyloid-Related Decline
Michael C. Donohue et al.
JAMA NEUROLOGY (2014)
Uric acid and chronic kidney disease: which is chasing which?
Richard J. Johnson et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Using Allopurinol Above the Dose Based on Creatinine Clearance Is Effective and Safe in Patients With Chronic Gout, Including Those With Renal Impairment
Lisa K. Stamp et al.
ARTHRITIS AND RHEUMATISM (2011)
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Marian Goicoechea et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Allopurinol Use Yields Potentially Beneficial Effects on Inflammatory Indices in Those With Recent Ischemic Stroke A Randomized, Double-Blind, Placebo-Controlled Trial
Scott W. Muir et al.
STROKE (2008)
Pathological correlates of dementia in a longitudinal, population-based sample of aging
Joshua A. Sonnen et al.
ANNALS OF NEUROLOGY (2007)
Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia
Mattias Haglund et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol
P Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Hyperuricemia induces endothelial dysfunction
UM Khosla et al.
KIDNEY INTERNATIONAL (2005)
Drug delivery to brain via the blood-brain barrier
JM Scherrmann
VASCULAR PHARMACOLOGY (2002)
Share Paper
